Locoregional Chemoembolic Delivery: Prediction With Transcatheter Intraarterial Perfusion MRI

摘要

Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver and the sixth lending cause of cancer worldwide. Although hepatic resection and liver transplant have 5-year survival rates of 50-70%, morethan 80% of patients are not surgical candidates. Several transcatheter approaches have been developed to treat unresectable tumors by injection of therapeutic agents into the hepatic arterial blood supply. These methods include trans-arterial embolization with bland particles, transarterial chemoembolization with iodized oil or drug-eluting beads, and radio-embolization with ~90Y microspheres.